
About Avance Clinical
Avance Clinical is a Healthcare company based in Thebarton (Australia) founded in 2018. Clinical development services are provided to pharmaceutical clients worldwide. Avance Clinical has completed 2 acquisitions, including C3 Research Associates and LumaBridge. Its chief executive, as recorded, is Yvonne Lungershausen. Its website avancecro.com draws about 20 thousand monthly visits. Its Indian entity Avance Clinical India Private Limited reported revenue of ₹9.35 Cr. Avance Clinical offers products and services including Clinical Operations, Data Management, Biostatistics, and Patient Recruitment. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Early Stage.
Company details
Avance Clinical was founded in 2018 and is headquartered in Thebarton, Australia. Operations focus on the contract research organization sector, where clinical development services are delivered to support pharmaceutical and biotechnology firms. These services encompass trial management, regulatory compliance, and data analysis, with activities spanning multiple therapeutic areas. Leadership is provided by CEO Yvonne Lungershausen, ensuring oversight of global projects.
- Headquarters Thebarton, Australia
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website avancecro.com
- Social LinkedIn X
- Legal Name Avance Clinical India Private Limited
- Date of Incorporation 28 Oct, 2022
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹9.35 Cr
FY 2025 · +199% YoY
- Indian entity net profit₹75.3 Lakh
FY 2025 · 8% margin
- Indian entity EBITDA₹1.04 Cr
FY 2025 · 11% margin
- Investors
- Investments & AcquisitionsC3 Research Associates
& 1 more
Associated legal entities of Avance Clinical
Avance Clinical operates through Avance Clinical India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Avance Clinical India Private Limited CIN U73100KA2022FTC167429 | Active | 28 Oct 2022 | Bangalore, Karnataka | ₹9.4 Cr | 18 | 3 | View details |
Products & Services of Avance Clinical
Avance Clinical offers a comprehensive portfolio of products and services, including Clinical Operations, Data Management, Biostatistics, and Patient Recruitment.
Manages clinical trial processes for biotechs
Handles data collection and analysis in trials
Provides statistical analysis for clinical studies
Facilitates participant enrollment in trials
Funding Insights of Avance Clinical
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Avance Clinical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2021 | Private Equity Round | – | Riverside | – |
1 investors in total: 1 institutional.
Investors in Avance Clinical
Avance Clinical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Riverside Company.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and debt are provided to middle market companies. | riversidecompany.com | Cleveland, United States |
Investor details for Avance Clinical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Avance Clinical India Private Limited (Avance Clinical)
Avance Clinical India Private Limited is the primary company behind Avance Clinical. The board of Avance Clinical India Private Limited currently have 3 directors; the longest-serving is Gregory Charles Vella, appointed in 2022. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Gregory Charles Vella DIN 09776284 | Director | 28 Oct 2022 | 4 yrs | Avance Clinical India Private Limited |
| Yadehalli Gundurao Ramya DIN 10330968 | Director | 22 Sep 2023 | 3 yrs 2 mo | Avance Clinical India Private Limited |
| Mark Landon Harvill DIN 11219851 | Additional Director | 30 Jul 2025 | 1 yr 3 mo | Avance Clinical India Private Limited |
People of Avance Clinical
8 people are tracked at Avance Clinical (1 in leadership, 7 in board & advisors).
| Name | Role | Group |
|---|---|---|
| CEO | Leadership | |
Stuart Baxter | Board Member | Board & advisors |
Herman Scholtz | Director | Board & advisors |
Daniel Spasic | Board Member | Board & advisors |
Kevin Xu | Board Member | Board & advisors |
Glenn Haifer | Chairman | Board & advisors |
Caroline Popper | Director | Board & advisors |
Alek Safarian | Board Member | Board & advisors |
Complete people profiles for Avance Clinical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Avance Clinical
Figures of Avance Clinical India Private Limited, the primary company behind Avance Clinical, for FY 2025. Revenue was ₹9.35 Cr (+199% year on year). Net profit was ₹75.3 Lakh (8% margin). EBITDA was ₹1.04 Cr (11% margin).
- ₹9.35 CrRevenue · FY 2025 · +199% YoY
- ₹75.3 LakhNet profit · 8% margin
- ₹1.04 CrEBITDA · 11% margin
- ₹50,000Paid-up capital
- 18Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Avance Clinical India Private Limited are on its company page.
Detailed financial statements for Avance Clinical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avance Clinical
Avance Clinical has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include C3 Research Associates and LumaBridge.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of oncology clinical research, regulatory affairs, and data management services | lumabridge.com | San Antonio, United States | 2000 | Jan 2026 | •••• | |
CRO specializing in adaptive clinical trials | c3-research.com | Seattle, United States | 2008 | Sep 2022 | •••• |
Complete acquisition details for Avance Clinical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Avance Clinical
4 dated milestones of Avance Clinical across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Avance Clinical is founded.
- Funding First funding round.
- Acquisition Acquires C3 Research Associates.
- Acquisition Acquires LumaBridge.
Web traffic of Avance Clinical
The website of Avance Clinical (avancecro.com) receives about 19.6K visits a month.
- Monthly visits19.6K
▲ 39.3% vs previous month
Websites whose visitors overlap most with Avance Clinical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
victrials.com.au | victrials.com.au | 100% | #4,799,626 | – | |
accelagen.com.au | accelagen.com.au | 95% | – | ||
| paratusclinical.com | 93% | 12.7K | #1,515,022 | View details | |
momentumclinicalresearch.com.au | momentumclinicalresearch.com.au | 91% | #1,089,398 | – | |
| roche-australia.com | 78% | 680.7K | #4,116,011 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Avance Clinical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Avance Clinical
Complete news archive for Avance Clinical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avance Clinical
Avance Clinical was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Avance Clinical is headquartered in Thebarton, Australia. It is registered at Thebarton, South Australia, Australia.
Yvonne Lungershausen is the CEO of Avance Clinical, as recorded in our data.
The primary company behind Avance Clinical, Avance Clinical India Private Limited, reported revenue of ₹9.35 Cr for FY 2025, up 199% year on year.
Avance Clinical was founded in 2018 and is headquartered in Thebarton, Australia. Operations focus on the contract research organization sector, where clinical development services are delivered to support pharmaceutical and biotechnology firms. These services encompass trial management, regulatory compliance, and data analysis, with activities spanning multiple therapeutic areas. Leadership is provided by CEO Yvonne Lungershausen, ensuring oversight of global projects.
Avance Clinical offers Clinical Operations, Data Management, Biostatistics, and Patient Recruitment.
Avance Clinical has made 2 acquisitions, including C3 Research Associates, and LumaBridge.
Avance Clinical has 1 investor. Key investors include The Riverside Company.
Avance Clinical operates through Avance Clinical India Private Limited.
The legal entities of Avance Clinical currently have 3 directors, including Yadehalli Gundurao Ramya, Gregory Charles Vella, Mark Landon Harvill.
